While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here is one profitable company that generates reliable profits without sacrificing growth and two best left off your watchlist.
Two Stocks to Sell:
CSX (CSX)
Trailing 12-Month GAAP Operating Margin: 32.1%
Established as part of the Chessie System and Seaboard Coast Line Industries merger, CSX (NASDAQ: CSX) is a transportation company specializing in freight rail services.
Why Do We Think CSX Will Underperform?
- Flat unit sales over the past two years suggest it might have to lower prices to accelerate growth
- Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable
- Free cash flow margin dropped by 18 percentage points over the last five years, implying the company became more capital intensive as competition picked up
CSX’s stock price of $42.37 implies a valuation ratio of 23.1x forward P/E. Dive into our free research report to see why there are better opportunities than CSX.
Bunge Global (BG)
Trailing 12-Month GAAP Operating Margin: 1.8%
With origins dating back to 1818 and operations spanning both hemispheres to balance seasonal harvests, Bunge Global (NYSE: BG) is an agribusiness and food company that processes oilseeds, grains, and other agricultural commodities into vegetable oils, protein meals, flours, and specialty ingredients.
Why Are We Wary of BG?
- The company has faced growth challenges as its 1.5% annual revenue increases over the last three years fell short of other consumer staples companies
- Earnings per share fell by 19.1% annually over the last three years while its revenue grew, showing its incremental sales were much less profitable
- Unfavorable liquidity position could lead to additional equity financing that dilutes shareholders
Bunge Global is trading at $120.18 per share, or 14.9x forward P/E. To fully understand why you should be careful with BG, check out our full research report (it’s free).
One Stock to Watch:
Cardinal Health (CAH)
Trailing 12-Month GAAP Operating Margin: 1%
Operating as a critical link in the healthcare supply chain since 1979, Cardinal Health (NYSE: CAH) distributes pharmaceuticals and manufactures medical products for hospitals, pharmacies, and healthcare providers across the global healthcare supply chain.
Why Do We Like CAH?
- Unparalleled scale of $244.7 billion in revenue gives it negotiating leverage and staying power in an industry with high barriers to entry
- Demand will likely accelerate over the next 12 months as its forecasted revenue growth of 10.6% is above its two-year trend
- Earnings per share grew by 10.2% annually over the last five years, comfortably beating the peer group average
At $231.85 per share, Cardinal Health trades at 20.9x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
